Roche Holding AG (XSWX:ROP) Interest Expense: CHF-1,346 Mil (TTM As of Dec. 2025)


XSWX:ROP Roche Holding AG XSWX:ROP
77 GF Score
Price CHF336.00
GF Value CHF264.69
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG Interest Expense?

Roche Holding AG XSWX:ROP +0.21% 77 Interest Expense is CHF-1,346 Mil as of Dec. 2025. GuruFocus rates XSWX:ROP with a GF Score™ of 77/100 and a GF Value™ of CHF264.69 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Roche Holding AG's interest expense for the six months ended in Dec. 2025 was CHF -654 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-1,346 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Roche Holding AG's Operating Income for the six months ended in Dec. 2025 was CHF 8,146 Mil. Roche Holding AG's Interest Expense for the six months ended in Dec. 2025 was CHF -654 Mil. Roche Holding AG's Interest Coverage for the quarter that ended in Dec. 2025 was 12.46. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Roche Holding AG  (XSWX:ROP) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Roche Holding AG's Interest Expense for the six months ended in Dec. 2025 was CHF-654 Mil. Its Operating Income for the six months ended in Dec. 2025 was CHF8,146 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was CHF28,674 Mil.

Roche Holding AG's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*8146/-654
=12.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Roche Holding AG Interest Expense Historical Data

* Premium members only.

The historical data trend for Roche Holding AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Interest Expense Chart

Roche Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -419.00 -690.00 -997.00 -1,403.00 -1,346.00

Roche Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -508.00 -706.00 -697.00 -692.00 -654.00
XSWX:ROP
77GF Score
Roche Holding AG XSWX:ROP
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roche Holding AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-1,346 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of CHF-1,346 Mil mean?
Roche Holding AG (XSWX:ROP) has a Interest Expense of CHF-1,346 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Roche Holding AG and its competitors.
Is Roche Holding AG's Interest Expense too high?
Roche Holding AG's current Interest Expense is CHF-1,346 Mil. Overall, Roche Holding AG has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Roche Holding AG's Interest Expense compare to LLY and JNJ?
Roche Holding AG's Interest Expense of CHF-1,346 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Roche Holding AG and its competitors. Roche Holding AG's current Interest Expense is CHF-1,346 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roche Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Roche Holding AG (XSWX:ROP) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF264.69, compared to a current price of CHF336.00 — trading 26.9% above its estimated fair value. The current Interest Expense is CHF-1,346 Mil. Roche Holding AG's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Roche Holding AG (XSWX:ROP), the current Interest Expense is CHF-1,346 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Roche Holding AG (XSWX:ROP) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF336.00 is trading 26.9% above its estimated GF Value™ of CHF264.69. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XSWX:ROP:

  • Interest Expense: CHF-1,346 Mil
  • GF Value™: CHF264.69 vs. price of CHF336.00 (26.9% above fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the XSWX:ROP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
77GF Score

Get the complete analysis for XSWX:ROP

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF336.00
Price
CHF264.69
GF Value